Company / Capital Expenditures
Guardant Health, Inc. Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$48.3M
FY2025
5-year range
$20.5M / $77.5M
FY2021-FY2025
Trend
+37.7%
vs FY2024
Sector context
#76 of 145
Health Care
What the data says
At $48M, Guardant Health, Inc.'s capital expenditures ranks #76 of 145 in the Health Care sector. Capital Expenditures has fluctuated over the past 10 years, ranging from $2M in FY2016 to $77M in FY2022.
Based on SEC 10-K filings.
$48M in FY2025 with a 5-year CAGR of +6.0%.
Improved from $20M to $48M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -14.6%
- 5-Year CAGR
- +6.0%
- 10-Year CAGR
- -
Sector benchmark
#76 of 145 in Health CareTop 52% of 145This company $48.3M Sector average $268.6M
▼
-82.0% below sector average
Key checks
Key Insights
- 5-year CAGR of +6.0%, indicating consistent growth.
- In FY2025, capital expenditures increased 37.7% year-over-year.
- Ranks #76 out of 145 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2022.
Company context
Key Data Points
- Altman Z-Score -1.05 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $48.3M | +37.7% |
| FY2024 | $35.1M | +71.3% |
| FY2023 | $20.5M | -73.6% |
| FY2022 | $77.5M | +3.2% |
| FY2021 | $75.0M | +107.4% |
| FY2020 | $36.2M | +93.3% |
| FY2019 | $18.7M | -7.4% |
| FY2018 | $20.2M | +202.4% |
| FY2017 | $6.7M | +278.3% |
| FY2016 | $1.8M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026